Companies
CollPlant
an Israeli-European player producing highly pure recombinant human collagen (rhCollagen) as a premium foundation for commercial bioinks.
- Country
- Israel
- Ticker
- CLPT
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| fibers-textiles | ✓ | ✓ | — | ✓ |
| regenerative-personalized | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Approximately $2.3 million in net proceeds from a private placement of ordinary shares and warrants. (2026-07-06) | sec.gov |
| Certification | ISO13485:2016 certification and DEKRA (European Union Notified Body) certification for the manufacturing and purification of rhCollagen at its Rehovot facility. (2019-02-19) | ir.collplant.com |
| Production site | A 6,000 square foot production facility in Rehovot, Israel, designed for purification of rhCollagen and formulation of end-products. (2019-02-19) | ir.collplant.com |
| Headcount | Reduced by approximately 50% as part of a cost-cutting plan announced in April 2026. (2026-04-13) | everyticker.com · ir.collplant.com · stocktitan.net |
| Revenue | $73,000 for the first quarter of 2026. (2026-03-31) | prnewswire.com · stocktitan.net |
| Capacity | The company has experience manufacturing limited quantities of rhCollagen and is working to increase its commercial-scale production capacity. Its Rehovot facility includes equipment to support production demand for several years. medium confidence | ir.collplant.com |
Independent sources: everyticker.com · prnewswire.com · sec.gov · stocktitan.net
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Organ & tissue bioprinting | regenerative-personalized | High | → |
| Recombinant collagen & gelatin | fibers-textiles | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.